The US Food and Drug Administration (FDA) has permitted marketing of the first
artificial intelligence (AI)-based medical device to detect certain diabetes-related eye problems. The device can detect more than mild level of the eye disease diabetic retinopathy in adults who have diabetes, FDA said in a ...